Meta-Analysis
Copyright ©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 7, 2014; 20(9): 2412-2419
Published online Mar 7, 2014. doi: 10.3748/wjg.v20.i9.2412
Table 2 Symptom response in ten studies
ReferenceInterventionCombined therapy, improved/treatedSingle therapy, improved/treated
Cho et al[24], 2013Esomeprazole 40 mg/d + mosapride 30 mg tid19/2413/19
Hsu et al[2], 2010Lansoprazole 30 mg/d + mosapride 5 mg tid39/4441/50
Madan et al[19], 2004Pantoprazole 40 mg bid + mosapride 5 mg tid25/2823/33
Miwa et al[12], 2011Omeprazole 10 mg/d+ mosapride 5 mg tid45/9742/95
van Rensburg et al[25], 2001Pantoprazole 40 mg/d + cisapride 20 mg bid120/173129/177
Vigneri et al[26], 1995Omeprazole 40 mg/d + cisapride 10 mg tid31/3528/35
Beaumont et al[27], 2009PPI + baclofen 20 mg tid4/126/12
Boeckxstaens et al[22], 2011PPI + lesogaberan 65 mg bid21/10411/105
Shaheen et al[28], 2013PPI + lesogaberan 60/120/180/240 mg bd110/45822/122
Vakil et al[23], 2013PPI + baclofen 20/40/60 mg qd110/24021/54